Regulation of Mucosal Inflammation by Th17 Subsets
Th17 亚群对粘膜炎症的调节
基本信息
- 批准号:7757163
- 负责人:
- 金额:$ 22.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
T helper (Th) cells in lymphoid tissues, depending on their location, develop into various Th subsets to
regulate inflammation and defense. In the intestinal mucosa, fheir dominant phenotype is that of regulatory
T (Treg) cells. Mucosal adjuvants, by overriding the tolerizing impact of mucosal Treg cells, are unique tools
for dissecting immune regulation and inflammafion. Our preliminary data indicate that cholera toxin (CT)
and related compounds induce Thi7 cell differentiation via a cAMP-dependent and IL-6/TGF(3-independent
pathway. To elucidate the mechanism by which adenylyl cyclase toxins and other luminal microbial
products (TLR ligands) stimulate and modulate the mucosal microenvironment to promote effector Thi7
responses, we propose in Aim 1 to define how oral CT administrafion enhances Th17-promoting dendritic
cells (DC) and suppresses Treg-promoting DC. We will explore the role of cAMP and retinoic acid in these
processes, and characterize the subsequent Th cell response provoked by different MLN DC subsets. In
Aim 2, we will characterize the phenotype, stability and lineage differentiation markers of CD4 T cells from
in vitro- and in vivo-differentiated CT-induced Thi7 subsets, and evaluate the infiammatory/regulatory
impact of orally delivered CT on the outcome of Thi7 cell-mediated colitis. Aim 3 will explore the role of
CGRPP produced by CT-activated DC in a mucosal Thi7 response. Aim 4 will investigate the potential
contributing role of TLR stimulation to CT-induced Thi7 differentiation. Dissecting the impact of CT and
other cAMP-inducing compounds on mucosal DC maturation will significantiy broaden our knowledge on
the generation of mucosal Th responses. By dissecting the lineage stability of CT-induced mucosal Thi7
cells, their effector function, lineage commitment, trafficking and their interactions with other Th cells, we will
increase our understanding of the regulation of inflammation and immunity at mucosal sites. The data
generated in these studies may help to design new therapeutic approaches for mucosal inflammatory
diseases and novel mucosal adjuvants.
RELEVANCE (See instmctions):
Mucosal adjuvants are critical for success of oral vaccination strategies, since antigen exposure alone does
not elicit protective immunity. The studies are designed to increase the understanding of the mechanisms
by which such adjuvants promote protective immunity, and will also generate new insights into the natural
mechanisms by which the gut maintains normal immune homeostasis.
淋巴组织中的T助手(Th)细胞,取决于其位置,发展成各种子集
调节炎症和防御。在肠粘膜中,FHEIR显性表型是调节的
T(Treg)细胞。粘膜佐剂通过覆盖粘膜Treg细胞的耐受影响是独特的工具
用于解剖免疫调节和炎症。我们的初步数据表明霍乱毒素(CT)
相关化合物通过CAMP依赖性和IL-6/TGF诱导Thi7细胞分化(3个独立
路径。阐明腺苷酸环化酶毒素和其他腔微生物的机制
产品(TLR配体)刺激并调节粘膜微环境以促进效应子Thi7
回答,我们在AIM 1中提出了旨在定义口服CT Idministrafion如何增强TH17促进树突状的
细胞(DC)并抑制促进Treg的DC。我们将探索营地和视黄酸在这些中的作用
过程,并表征随后由不同的MLN DC子集引起的细胞响应。在
AIM 2,我们将表征CD4 T细胞的表型,稳定性和谱系分化标记
体外和体内分化的CT诱导的Thi7子集,并评估侵害性/调节性
口服递送CT对Thi7细胞介导的结肠炎结果的影响。 AIM 3将探讨
CT激活的DC在粘膜Thi7响应中产生的CGRPP。 AIM 4将调查潜力
TLR刺激对CT诱导的Thi7分化的作用。剖析CT的影响
其他关于粘膜DC成熟的营地诱导化合物将大大扩大我们对
粘膜的产生。通过剖析CT诱导的粘膜Thi7的谱系稳定性
细胞,效应子功能,谱系承诺,运输及其与其他TH细胞的相互作用,我们将
提高我们对粘膜部位炎症和免疫力的调节的理解。数据
在这些研究中产生的可能有助于设计新的治疗方法来粘膜炎症
疾病和新型粘膜佐剂。
相关性(请参阅Instmctions):
粘膜佐剂对于口服疫苗接种策略的成功至关重要,因为仅抗原暴露才能
不引起保护性免疫。研究旨在增加对机制的理解
通过这种佐剂促进保护性免疫,还将产生对自然的新见解
肠道维持正常免疫稳态的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Eyal Raz的其他基金
A novel pathway of Th17/Th2 induction: The role of cAMP signaling in DC
Th17/Th2 诱导的新途径:cAMP 信号在 DC 中的作用
- 批准号:1033102410331024
- 财政年份:2019
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
Control of mucosal immunity by Gas- vs Gai-linked GPCR signaling in dendritic cells
树突状细胞中 Gas 与 Gai 连接的 GPCR 信号传导控制粘膜免疫
- 批准号:92881249288124
- 财政年份:2016
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
Control of mucosal immunity by Gas- vs Gai-linked GPCR signaling in dendritic cells
树突状细胞中 Gas 与 Gai 连接的 GPCR 信号传导控制粘膜免疫
- 批准号:91698329169832
- 财政年份:2016
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa
Th17 亚群:G-I 粘膜免疫防御机制中的不同作用
- 批准号:88715618871561
- 财政年份:2011
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa
Th17 亚群:G-I 粘膜免疫防御机制中的不同作用
- 批准号:87112388711238
- 财政年份:2011
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa
Th17 亚群:G-I 粘膜免疫防御机制中的不同作用
- 批准号:84872008487200
- 财政年份:2011
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa
Th17 亚群:G-I 粘膜免疫防御机制中的不同作用
- 批准号:82875208287520
- 财政年份:2011
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa
Th17 亚群:G-I 粘膜免疫防御机制中的不同作用
- 批准号:81802208180220
- 财政年份:2011
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
The Impact of TLR on Intestinal Tumorigenesis
TLR 对肠道肿瘤发生的影响
- 批准号:77384517738451
- 财政年份:2009
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
The Impact of TLR on Intestinal Tumorigenesis
TLR 对肠道肿瘤发生的影响
- 批准号:78228617822861
- 财政年份:2009
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
相似国自然基金
皮内接种抗原佐剂复合疫苗跨器官诱导呼吸道黏膜免疫反应
- 批准号:82341042
- 批准年份:2023
- 资助金额:100 万元
- 项目类别:专项基金项目
酵母菌@金属有机框架复合微颗粒佐剂增强树突状细胞递呈抗原能力的分子机制
- 批准号:32302891
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸新型佐剂构建及在增强抗原表位免疫原性中的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
框架核酸新型佐剂构建及在增强抗原表位免疫原性中的研究
- 批准号:22277071
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
基于新型双膦酸盐佐剂和表位嵌合颗粒抗原的乙肝治疗性疫苗疗效与机制研究
- 批准号:32170943
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
相似海外基金
Development of mucosal vaccines to protect against pertussis
开发预防百日咳的粘膜疫苗
- 批准号:1033333310333333
- 财政年份:2019
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
Development of mucosal vaccines to protect against pertussis
开发预防百日咳的粘膜疫苗
- 批准号:1054822210548222
- 财政年份:2019
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
Development of mucosal vaccines to protect against pertussis
开发预防百日咳的粘膜疫苗
- 批准号:1008425710084257
- 财政年份:2019
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
Systematic evaluation of B. pertussis ACT’s role as a protective antigen
百日咳博德特氏菌 ACT 作为保护性抗原的作用的系统评估
- 批准号:90562319056231
- 财政年份:2015
- 资助金额:$ 22.82万$ 22.82万
- 项目类别:
Modeling distinct neonatal purine metabolism to inform vaccine development
模拟不同的新生儿嘌呤代谢为疫苗开发提供信息
- 批准号:86926398692639
- 财政年份:2012
- 资助金额:$ 22.82万$ 22.82万
- 项目类别: